Cargando…

A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD

BACKGROUND: Oral corticosteroids (OCS) are often prescribed for chronic obstructive pulmonary disease (COPD) exacerbations. METHODS: This observational, individually matched historical cohort study used electronic medical records (1987–2019) from the UK Clinical Practice Research Datalink linked to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tse, Gary, Emmanuel, Benjamin, Ariti, Cono, Bafadhel, Mona, Papi, Alberto, Carter, Victoria, Zhou, Jiandong, Skinner, Derek, Xu, Xiao, Müllerová, Hana, Price, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657769/ https://www.ncbi.nlm.nih.gov/pubmed/38022830 http://dx.doi.org/10.2147/COPD.S433326

Ejemplares similares

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
por: Heatley, Heath, et al.
Publicado: (2023)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
por: Camp, James, et al.
Publicado: (2018)

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
por: Nicolau, Dan V, et al.
Publicado: (2020)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
por: Haughney, John, et al.
Publicado: (2023)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections
por: Chico, R. Matthew, et al.
Publicado: (2017)

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
por: Magnussen, Helgo, et al.
Publicado: (2021)

Inhaled corticosteroids, blood eosinophils, and FEV(1) decline in patients with COPD in a large UK primary health care setting
por: Whittaker, Hannah R, et al.
Publicado: (2019)

Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study
por: Carney, A Simon, et al.
Publicado: (2017)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
por: Benson, Victoria S, et al.
Publicado: (2019)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
por: Scichilone, Nicola, et al.
Publicado: (2014)

Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019
por: Halpin, David M.G., et al.
Publicado: (2019)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
por: Miravitlles, Marc, et al.
Publicado: (2021)

Renaming COPD exacerbations: the UK respiratory nursing perspective
por: Mwasuku, Christine, et al.
Publicado: (2021)

Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
por: David, Benjamin, et al.
Publicado: (2021)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study
por: Halpin, David M.G., et al.
Publicado: (2023)

Tailoring of corticosteroids in COPD management
por: De Coster, Daan A., et al.
Publicado: (2014)

Effect of telehealth on hospital utilisation and mortality in routine clinical practice: a matched control cohort study in an early adopter site
por: Steventon, Adam, et al.
Publicado: (2016)

The impact of alcohol care teams on emergency secondary care use following a diagnosis of alcoholic liver disease - a national cohort study
por: Currie, Claire, et al.
Publicado: (2016)

Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study
por: Müllerová, Hana, et al.
Publicado: (2014)

Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children
por: Yao, Tsung-Chieh, et al.
Publicado: (2021)

Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
por: Valvi, Deepa, et al.
Publicado: (2012)

Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
por: Karlsson, Niklas, et al.
Publicado: (2021)

Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies
por: Meeraus, Wilhelmine H, et al.
Publicado: (2021)

Building a better understanding of labour exploitation's impact on migrant health: An operational framework
por: Boufkhed, Sabah, et al.
Publicado: (2022)

Risk factors for adverse outcomes in women with high-risk pregnancy and their neonates, Haiti
por: Schuurmans, Jorien, et al.
Publicado: (2021)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care
por: Rothnie, Kieran J, et al.
Publicado: (2017)

Clinical burden of illness among patients with severe eosinophilic COPD
por: Müllerová, Hana, et al.
Publicado: (2019)

Neutrophil elastase as a biomarker for bacterial infection in COPD
por: Thulborn, Samantha J., et al.
Publicado: (2019)

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
por: Müllerová, Hana, et al.
Publicado: (2019)

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
por: Price, David B, et al.
Publicado: (2022)

Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI
por: Bogart, Michael, et al.
Publicado: (2023)

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
por: Singh, Dave, et al.
Publicado: (2021)

Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011–2014
por: Schillberg, Erin, et al.
Publicado: (2016)

Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study
por: Wurst, Keele E, et al.
Publicado: (2014)

Building toolkits for COPD exacerbations: lessons from the past and present
por: Sapey, Elizabeth, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2jspt9rleas8icn258vcgernqa